Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
Richard F Pollock,1 Yujun Qian,2 Tami Wisniewski,3 Lisa Seitz,4 Anne-Marie Kappelgaard2 1Ossian Health Economics and Communications GmbH, Basel, Switzerland; 2Novo Nordisk AS, Bagsværd, Denmark; 3Novo Nordisk Inc, Princeton, NJ, USA; 4Novo Nordisk Pharma GmbH, Mainz, Germany Background: Tr...
Guardado en:
Autores principales: | Pollock RF, Qian Y, Wisniewski T, Seitz L, Kappelgaard AM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eecb0afab0d4b5ebc5a216b47c0bbb4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study
por: Rapaport R, et al.
Publicado: (2013) -
Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation
por: Guiffant G, et al.
Publicado: (2012) -
Emerging technologies in paediatric laboratory medicine
por: Mak Chloe, et al.
Publicado: (2021) -
A new journal for progress in Laboratory Medicine
por: Caballé Imma
Publicado: (2020) -
Atherectomy devices: technology update
por: Akkus NI, et al.
Publicado: (2014)